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The addition of asparagine (N)-linked polysaccharide chains (i.e., glycans) to the gp120 and gp41 glycoproteins of
human immunodeficiency virus type 1 (HIV-1) envelope is not only required for correct protein folding, but also may
provide protection against neutralizing antibodies as a ‘‘glycan shield.’’ As a result, strong host-specific selection is
frequently associated with codon positions where nonsynonymous substitutions can create or disrupt potential N-
linked glycosylation sites (PNGSs). Moreover, empirical data suggest that the individual contribution of PNGSs to the
neutralization sensitivity or infectivity of HIV-1 may be critically dependent on the presence or absence of other PNGSs
in the envelope sequence. Here we evaluate how glycan–glycan interactions have shaped the evolution of HIV-1
envelope sequences by analyzing the distribution of PNGSs in a large-sequence alignment. Using a ‘‘covarion’’-type
phylogenetic model, we find that the rates at which individual PNGSs are gained or lost vary significantly over time,
suggesting that the selective advantage of having a PNGS may depend on the presence or absence of other PNGSs in
the sequence. Consequently, we identify specific interactions between PNGSs in the alignment using a new paired-
character phylogenetic model of evolution, and a Bayesian graphical model. Despite the fundamental differences
between these two methods, several interactions are jointly identified by both. Mapping these interactions onto a
structural model of HIV-1 gp120 reveals that negative (exclusive) interactions occur significantly more often between
colocalized glycans, while positive (inclusive) interactions are restricted to more distant glycans. Our results imply that
the adaptive repertoire of alternative configurations in the HIV-1 glycan shield is limited by functional interactions
between the N-linked glycans. This represents a potential vulnerability of rapidly evolving HIV-1 populations that may
provide useful glycan-based targets for neutralizing antibodies.
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Introduction
Proteins are frequently modiﬁed during or after trans-
lation by the enzymatic attachment of polysaccharide chains
(i.e., glycans) to amino acid residues. The addition of glycans
to asparagine residues is known as N-linked glycosylation and
occurs widely in eukaryotes and archaebacteria, but only
rarely in prokaryotes [1]. N-linked glycosylation targets an
amino acid sequence motif that is deﬁned by NX1(S/T)X2,
where X represents any amino acid other than proline [2].
Glycosylation by the host cell can strongly inﬂuence the
folding, stability, and biological function of virus-encoded
proteins [3–5]. As a result, many viral sequences contain a
large number of conserved potential N-linked glycosylation
sites (PNGSs) [6,7].
For instance, the surface glycoprotein (gp120) of the
human immunodeﬁciency virus type 1 (HIV-1) envelope,
which represents the primary interface between the virus and
the host environment, is one of the most heavily glycosylated
proteins known to date, with nearly half of its molecular
weight due to the addition of N-linked glycans [8]. The
transmembrane glycoprotein (gp41) of the HIV-1 envelope is
also glycosylated, but to a lesser extent. The addition of N-
linked glycans is essential for HIV-1 gp120 to fold into the
proper conformation to bind to the CD4 receptor [9], and
inﬂuences the binding of alternative coreceptors [7,10], the
combined effects mediating the fusion and entry of HIV-1
into the host cell. Furthermore, N-linked glycans can steri-
cally prevent neutralizing antibodies from accessing the
antigenic polypeptide surface of the HIV-1 envelope, thereby
protecting the virus from the humoral immune response with
a ‘‘glycan shield’’ [11]. Strains of HIV-1 in which N-linked
glycosylation sites have been experimentally deleted or
modiﬁed can become more sensitive to neutralization [12].
However, the relative contribution of the glycan shield to
protection from neutralization in vivo remains unresolved
[13].
Because many N-linked glycans are highly conserved
components of the HIV-1 envelope, they may themselves
provide a promising target for neutralizing antibodies; for
instance, the broadly neutralizing human monoclonal anti-
body 2G12 binds to an epitope comprising N-linked glycans
that are attached to the gp120 glycoprotein [14]. There is,
however, abundant evidence that host-speciﬁc adaptation of
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example, codon positions under strong host-speciﬁc selection
in HIV-1 gp120 sequences often occur within PNGSs
[11,15,16]. Although many PNGSs are evolutionarily con-
served, there is nonetheless ample variation in the distribu-
tion of PNGSs among HIV-1 sequences that is poorly
understood. Moreover, empirical evidence suggests that the
inﬂuence of PNGSs on the ﬁtness of HIV-1 is context-
dependent, i.e., conditional on the presence or absence of
other PNGSs in the viral sequence. First, the experimental
reintroduction of individual PNGSs to a neutralization-
sensitive HIV-1 clone by Wei et al. [11] had only modest
effects on neutralization sensitivity, yet the combined
introduction of multiple PNGSs revealed a positive inter-
action causing a disproportionate increase in resistance to
neutralization. Second, Ohgimoto et al. [17] demonstrated
that a strain of simian immunodeﬁciency virus (SIV) could
not tolerate the removal of multiple N-linked glycans from
gp120, if the glycans were speciﬁcally removed from the same
location. Apart from these ﬁndings, the extent and identity of
such interactions among PNGSs that constitute the HIV-1
glycan shield has not yet been systematically characterized.
Detecting Interactions
Developing an efﬁcient and accurate method to detect
interactions between components of the same protein, or
between different proteins, is an important and unresolved
problem in computational biology. One of the ﬁrst ap-
proaches was to apply a measure of the correlation in amino
acid composition at different codon positions in related
protein sequences [18,19]. However, this approach was limited
to pairwise interactions and could not readily distinguish
functional from phylogenetic relationships [20]. A complete
representation of interactions in a phylogenetic context can
be achieved by modeling the evolution of the entire sequence
through a state space of all possible sequences [21,22]. This
approach involves an excessive number of parameters—i.e.,
on the order of O(20
L) parameters for protein sequences of
length L—requiring approximate methods of parameter
estimation that are not necessarily statistically robust (e.g.,
Markov Chain Monte Carlo, MCMC). Another class of
phylogenetic models include the simplifying assumption that
the overall rate of evolution at a site depends on the states of
adjacent sites [23,24], contrary to the intuition that an
interaction drives substitutions to speciﬁc states. Even so,
these models remain computationally inefﬁcient.
In sum, there are a number of diverse methods that can be
applied towards identifying nonindependent evolution be-
tween positions in a sequence, but no consensus on which
method performs most reliably in practice. Furthermore,
other potentially useful approaches (e.g., Bayesian networks)
that can address speciﬁc weaknesses of existing methods have
yet to be applied to the study of covariation within evolving
sequences. We propose to employ new methods that comple-
ment each other’s strengths, while addressing the weaknesses
of previous methods, to determine the subset of detectable
interactions that are robust to varying assumptions.
In this study, we evaluate whether the evolution of PNGSs in
theHIV-1envelopehasbeensigniﬁcantlyinﬂuencedbyglycan–
glycan interactions, and identify speciﬁc interactions between
PNGSs in the envelope glycoproteins gp120 and gp41 by the
application of phylogenetic and graphical models to a
published alignment of HIV-1 sequences. First, we verify that
the distribution of PNGSs is consistent with heterotachy, in
which site-speciﬁc rates of evolution vary over time due to
genetic or environmental interactions [25]. This is accom-
plished by evaluating a hidden rate-switching or ‘‘covarion’’
model[26,27]againstconstrainedphylogeneticmodelsofPNGS
evolution in a nested analysis based on maximum likelihood.
Second, we propose a stochastic model to directly identify
genetic interactions, using a new paired-character model of
PNGS evolution named the disequon model (where sequon refers
to the sequence motif deﬁning a PNGS). We use maximum
likelihood estimates of the disequon model parameters to
quantify the type and magnitude of interactions between every
pairwise combination of PNGSs in the alignment, within a
phylogenetic context. However, because each pairwise inter-
action is evaluated inisolation fromall other PNGSs, the model
is unable to identify higher-order interactions among PNGSs,
and therefore cannot guarantee that speciﬁc pairwise inter-
actions persist in the context of the entire glycan shield.
To capture these higher-order interactions, we investigate
interactions among PNGS using a probabilistic graphical
model. A graph consists of a number of nodes, each one
representing a variable (e.g., presence/absence of a PNGS),
that are connected by directed or undirected arcs. The
conditional dependence of one variable upon another is
represented by a directed arc connecting the corresponding
nodes, usually depicted as an arrow. Nodes that are not
connected by arcs are conditionally independent. In practice,
a directed graph is required to be acyclic so that a chain of
directed arcs does not form a feedback loop to its parent
node—such a graph is commonly referred to as a tree or
‘‘forest’’ of unrelated trees. Probabilistic models based on
directed acyclic graphs originate from the formulation of
path analysis by the evolutionary biologist Sewall Wright in
1921 [28], but are currently more widely known as Bayesian
networks [29]. There is an ongoing proliferation of studies
that apply Bayesian networks to problems in biology, such as
the analysis of gene expression data to infer the structure of
regulatory networks [30]. Bayesian networks confer several
advantages for analyzing biological data: (i) networks provide
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Author Summary
Many viruses exploit the complex machinery of the host cell to
modify their own proteins, by the enzymatic addition of sugar
molecules to specific amino acids. These sugars, or ‘‘glycans,’’ play
several important roles in the infective cycle of the virus. The
envelope of the human immunodeficiency virus type 1 (HIV-1), for
example, becomes coated with so many glycans that the virus can
become invisible to the protein-specific immune response of the
host. Although some glycans are evolutionarily conserved, many
others may be present within some hosts but absent in others, and
may even appear or disappear over the course of an infection in a
single host. To understand this variability, we have analyzed HIV-1
envelope sequences to identify cases where the presence of one
glycan was dependent on the presence or absence of another
(called glycan–glycan interactions). We used two newly developed
computational methods to detect these interactions, thereby
providing conclusive evidence of a new fundamental pattern: the
glycans that exclude each other tend to occur near the same spot
on the envelope, whereas glycans that occur together tend to be far
apart.
Evolution of the HIV-1 Glycan Shieldan intuitive visual representation of biological complexity; (ii)
they can explicitly incorporate experimental uncertainty and
missing observations; and foremost, (iii) an abundance of
algorithms for the inference of Bayesian networks from
empirical data is already available (reviewed in [31]).
Results
Diversity of PNGSs in HIV-1 Glycoproteins
We located 224 positions at which PNGSs occurred in at
least one sequence, out of 1,049 possible positions in an
alignment of 711 full-length HIV-1 envelope sequences. The
frequency of PNGS per codon position was highly variable,
with more than 65% of PNGSs present in fewer than 10% of
the sequences. About one-quarter of PNGSs (n ¼ 57) were
unique to a single sequence in the alignment and represented
either spurious variation in the position of a PNGS due to
uncertainty in the alignment of sequences or genuinely rare
glycosylation sites. An individual sequence encoding both
gp120 and gp41 contained 29.9 PNGS on average. We ﬁtted a
generalized linear model to the number of PNGS per
sequence (using the R function glm [32]), which revealed
subtype to be a signiﬁcant factor (Wald test: v4
2 ¼ 12.7, p ¼
0.012). This analysis was restricted to subtypes that were
represented by at least 40 nonrecombinant sequences in the
data (viz. A, B, C, D, and O) to avoid spurious results due to
small sample size. This effect of subtype was largely due to an
elevated number of PNGSs (’31.9) in O group sequences (n¼
44; z¼2.8, p¼0.005). For example, the PNGSs N59 and N229
(numbered according to their positions in the HxB2
reference sequence) were essentially unique to group O
sequences, as noted in a previous study [7].
Covarion Model Analysis
Likelihood and parameter estimates for the covarion
model and constrained models of PNGSs evolution are
summarized in Table S1. Variation among sites in the overall
rate of gain or loss of PNGS (a
 1) was strongly supported by
the data (v1
2 ¼ 960.4, p   0.001). This result was consistent
with prior observations that while some PNGSs are highly
conserved in HIV-1 envelope sequences, others are under
strong host-speciﬁc selection [7,11]. We found strong support
for rejecting the noncovarion model in favor of a model with
an unconstrained rate of switching between hidden states
(son, soff . 0; v2
2¼639.8, p   0.001). Allowing variation among
sites in the hidden-state switching rates (r
 1) provided an
additional signiﬁcant improvement of ﬁt to the data (v1
2 ¼
174.2, p   0.001). Although the mean switching rates (son and
soff) appeared to be roughly symmetric in the full model, the
nested model with the constraint soff ¼ son was rejected by a
likelihood-ratio test (LRT) (v1
2¼6.6, p¼0.01). In sum, the full
covarion model was favored by all criteria evaluated (AIC,
AICc, and BIC; Table S1) with the following parameter
estimates: son ¼ 0.08, soff ¼ 0.06, r01/r10 ¼ 0.29, r ¼ 0.75, and
a ¼ 0.46. Removal of sequences that were annotated as
subtype recombinants (n ¼ 219) had no discernible effect on
our results. Overall, the hypothesis that evolutionary rates for
the gain or loss of PNGSs were variable over time, i.e.,
heterotachy, was strongly supported by the data.
Disequon Model Analysis
We detected signiﬁcant interactions between PNGSs in the
disequon model for 22 out of 6,455 pairwise combinations
after applying a deliberately conservative Bonferroni correc-
tion for multiple comparisons (see Materials and Methods).
Nine of these pairs consisted of PNGSs that overlapped by
one or three residues and were located either in the variable
loops of gp120 (i.e., V1/V2 and V4) or gp41 (i.e., N624–N625).
Estimates of the interaction parameter (e) indicated that the
interactions between all overlapping pairs were negative (e ,
1), with a single exception. This exception involved PNGSs
introduced by insertions into the V1/V2 loop (alignment
positions 252 and 253) that were present at low frequencies in
the alignment (1.1% and 1.4%, respectively). However, both
PNGSs occurred together in a single subtype B sequence,
resulting in an unusually high estimate of e¼15.3 (v1
2¼17.5,
p ¼ 2.91 3 10
 8). It is worth noting that an unusually high
localized density of PNGSs was introduced into this sequence
by the insertion of the motif NNTSNNTSY into the V1/V2
loop, deﬁning four distinct PNGSs. This particular outcome
was handled as an outlier in subsequent analyses.
Table 1 summarizes the parameter estimates from the
disequon model for all nonoverlapping pairwise combina-
tions of PNGSs with a signiﬁcant interaction component (e 6¼
1). Unlike the overlapping PNGSs, positive interactions
between nonoverlapping PNGSs (e . 1, n ¼ 8) occurred
about as often as negative interactions (e , 1, n ¼ 5). Indeed,
we found that e increased signiﬁcantly with respect to the
intramolecular distance (measured in angstroms, A ˚ ), separat-
ing the asparagine residues of PNGSs with signiﬁcant pairwise
interactions (linear regression: F ¼ 15.8, df ¼ 1, p ¼ 0.001;
Figure 1). A similar trend was observed between e and the
primary distance (i.e., the number of residues separating the
PNGSs in the amino acid sequence; F¼10.0, df¼1, p¼0.005).
In other words, positive interactions tended to be restricted
to PNGSs that were sufﬁciently distant from one another in
the HIV-1 envelope glycoproteins.
Many pairwise interactions detected by the disequon model
involved PNGS that were located in the V4 loop of the HIV-1
envelope protein gp120 (i.e., N406, N411, N413). Also, several
PNGSs were involved in multiple pairwise interactions (e.g.,
N234, N295, and N411). The insertion of the sequon N411 in
the V4 loop, for example, was involved in eight of the 13
signiﬁcant pairwise interactions between nonoverlapping
PNGS, which suggested that N411 has a broad inﬂuence on
formation of a functional glycan shield.
Bayesian Network Analysis
To reduce the computational complexity of the analysis
while retaining our power to detect higher-order interac-
tions, we restricted our network search to a subset of 17
PNGS that occurred at intermediate frequencies (20%–80%)
in the alignment (Table S2). Figure 2A summarizes the
frequencies at which arcs connecting two PNGS in either
direction occurred in a total of 25,000 Bayesian networks
(inferred from 250 replicate optimizations times 100 random
samples from the alignment). Arcs between ten speciﬁc pairs
of PNGS occurred in more than 67% of the networks
generated from random samples. The next most frequent
undirected arc occurred in only 47% of the networks (Figure
2A). Consequently, we applied the ten arcs with strongest
support towards assembling a majority-rule consensus Baye-
sian network.
Figure 2B illustrates the consensus network assembled from
the ten undirected arcs with support values above the
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Evolution of the HIV-1 Glycan Shieldthreshold, which connected 14 of the 17 PNGSs. Several
PNGSs were conditionally dependent on more than one other
PNGS in the network, implying higher-order interactions
that would not have been captured by the disequon model.
The posterior-odds ratios (see Materials and Methods)
associated with the consensus arcs N134–N136 and N332–
N334 indicated that PNGSs were mutually exclusive at these
sites, which in both cases overlapped by two residues in the
amino acid sequence. This outcome was hardly surprising
because it is impossible for two well-deﬁned PNGSs to
overlap by two residues. However, the majority of arcs in
the consensus network represented long-range interactions.
The most acute instance of this occurred between the PNGSs
N295, N362, and N816, in which the latter is located on the
cytoplasmic tail of the transmembrane glycoprotein gp41,
and the other two are located on the outer surface of gp120.
This network analysis could not account for phylogenetic
relationships between sequences. To identify potential effects
of phylogeny in the consensus network, we generated
networks for subsets of HIV-1 envelope sequences that were
annotated as belonging to subtypes A, B, C, and D, or
circulating recombinant forms CRF01 and CRF02, using an
MCMC-based procedure that was designed for inferring
networks from small datasets. Because the number of
CRF02 sequences (n ¼ 17) was far too small to perform any
rigorous network analysis on 17 variables, the results from
this network were omitted. Overall, ﬁve out of the ten arcs
from the consensus network were recovered in more than
one subtype-speciﬁc network (Table 2). This subset included
every interaction that was identiﬁed by both the consensus
network and the disequon model. The absence of the
remaining consensus network interactions was possibly either
caused by subtype-founder effects, or represented an artifact
of limited sample size within subtypes.
We mapped PNGS from the consensus network to the
predicted three-dimensional structure of the folded glyco-
protein gp120 (Figure 3). Because several regions of gp120
were truncated in the structural analysis (e.g., variable loop
V1/V2), only seven PNGSs from the consensus network (N230,
N295, N332, N339, N362, N442, and N465) could be mapped
to the structural model [33]. Of the four arcs from the
Table 1. Parameter Estimates for Nonoverlapping PNGSs with Significant Interactions in the Disequon Model
Codon Positions b1 b2 d e LRT p-Value
Alignment HxB2
87 536 59 411 15.9 3.32 86.2 3.73 33.6 6.43 3 10
 9
203 536 156 411 0.38 3.91 1.51 0.41 22.7 1.89 3 10
 6
304 536 229 411 12.2 5.07 6.88 2.38 23.0 1.62 3 10
 6
311 429 234 332 0.2 3.30 0.05 1.16 29.7 5.04 3 10
 8
311 577 234 442 0.18 7.74 0.03 0.98 28.3 1.04 3 10
 7
311 608 234 (V5) 0.17 12.8 0.09 1.13 30.6 3.17 3 10
 8
374 536 293 411 5.97 5.78 2.23 2.11 22.7 1.89 3 10
 6
376 434 295 337 7.03 50.1 4.60 0.24 28.1 1.15 3 10
 7
376 577 295 442 0.57 1.85 6.43 0.43 22.9 1.71 3 10
 6
464 536 356 411 30.4 5.91 8.58 2.41 22.3 1.39 3 10
 6
527 536 406 411 0.33 6.82 0.19 2.05 34.4 4.49 3 10
 9
536 544 411 413 6.79 6.08 1.73 0.49 46.6 8.71 3 10
 12
536 1,021 411 824 5.03 7.65 0.13 2.32 20.8 5.10 3 10
 6
b1, b2, bias towards loss of PNGSs at the first and second sites, respectively.
d, asymmetry in overall rates of evolution between sites.
e, pairwise interaction parameter (e . 1 indicates positive and e , 1 negative interactions).
LRT, likelihood ratio test comparing the full disequon model with a nested model in which e was constrained to 1.
p-Values were obtained from a v1
2 distribution.
(V5) corresponds to a PNGS that is inserted into the fifth variable loop region of gp120 in some sequences, but has no equivalent in the HxB2 reference sequence.
doi:10.1371/journal.pcbi.0030011.t001
Figure 1. The Nature of Glycan Interactions Depends on Their
Intramolecular Distance
Potential PNGSs that were identified by the disequon model as having
significant interactions with other PNGSs were mapped to a structural
model of HIV-1 gp120. Intramolecular distances between interacting
PNGSs were measured using the visualization software UCSF Chimera
[53]. When an asparagine residue corresponding to a PNGS was not
present in the structural model, the distance between pairs was
approximated by 4.0 A ˚ times the number of residues separating the
PNGSs, to a maximum of five residues. If the number of residues
exceeded five, then the unmapped pair was omitted from the analysis.
doi:10.1371/journal.pcbi.0030011.g001
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Evolution of the HIV-1 Glycan Shieldconsensus network deﬁned by these PNGSs, two represented
positive interactions (N332–N339 and N230–N442) and the
remaining two negative interactions (N362–N465 and N295–
N442). Only one of these four interactions (N295–N442) had
been previously detected by our disequon analysis. Although
this was an insufﬁcient sample for a robust comparison, the
asparagine residues within PNGSs that participated in
negative interactions were located closer together (8.7 A ˚
and 10.8 A ˚ ) than those in positive interactions (14.8 A ˚ and
42.0 A ˚ ). This trend lent further support for our observation
that negative interactions tended to occur between co-
localized PNGSs, and positive interactions between distant
PNGSs.
Discussion
Constraints on the Glycan Shield
Although there is substantial evidence that the distribution
of PNGSs in the HIV-1 envelope glycoproteins is a perpet-
ually evolving phenotype, little is known about the complex-
ities of how it responds to host-speciﬁc selection. The
existence of negative interactions between PNGSs implies
that there is more than one way for the glycan shield to adapt
to the selective pressures of a given environment. To
determine whether this prediction is borne out empirically,
we evaluated the extent of convergent evolution of PNGSs in
a longitudinal study of 11 macaques that were experimentally
infected with a chimeric simian/human immunodeﬁciency
virus strain (SHIV-86P) containing an HIV-1 subtype B–
derived envelope coding region, as reported recently by Blay
et al. [34]. Despite substantial divergence in the amino acid
sequences from the replicate populations, convergent evolu-
tion occurred at several PNGSs (N141, N188, N276, N386,
N397, and N462), suggesting that the selective response was
highly constrained at those positions. In other words, the
selective advantage of these changes was apparently inde-
pendent of the presence or absence of other PNGS in the
envelope sequence. We have found no evidence in our study
Figure 2. Consensus Bayesian Network of Highly Polymorphic PNGSs in the HIV-1 Envelope
(A) Ordered distribution of frequencies that undirected links (i.e., arcs) occurred in replicate networks optimized on 100 random samples of 200
sequences from the alignment, expressed as a percentage (y-axis). A dotted line at 50% indicates an arbitrary cutoff, above which arcs were applied to
assembling the consensus network.
(B) Graph of consensus network. Each node (oval) represents the PNGS identified by its position in the HxB2 reference sequence, with one exception
(V2ins) that represents an inserted PNGS downstream of the conserved N186. Arcs between nodes are labeled with percentage of occurrence above
and odds-ratios below. An odds-ratio ,1 (red) indicates mutual exclusion and .1 (blue) co-occurrence of PNGSs.
doi:10.1371/journal.pcbi.0030011.g002
Table 2. Posterior Probabilities of Undirected Arcs in Subtype-Specific Networks
Subtype A (n ¼ 58) Subtype B (n ¼ 176) Subtype C (n ¼ 122) Subtype D (n ¼ 48) CRF 01 (n ¼ 35)
N332–N334 1.0 N332–N334 1.0 N332–N334 1.0 N332–N334 0.919 N136–V2ins 0.925
N411–N413 0.996 N411–N413 1.0 N134–N136 0.995 N295–N334 0.821
N295–N411 0.883 N134–N136 1.0 N295–N442 0.990 N406–N465 0.812
N332–N339 0.779 N295–N413 0.903 N406–N411 0.943 N339–N816 0.764
N230–N442 0.762 N334–N465 0.883 N130–N411 0.832 N289–N465 0.709
N136–N816 0.735 N295–N442 0.775 N406–N816 0.736
N406–N413 0.723 N442–N465 0.768 N465–N816 0.710
N295–N332 0.716 N406–N411 0.733
N134–N465 0.716
N334–N406 0.701
Undirected arcs with posterior probabilities below 70% are omitted from the table. Posterior probabilities were estimated by an order–MCMC procedure (see Materials and Methods).
Boldface indicates arcs that were identified in the consensus network. Numbering of the potential N-linked glycosylation sites is according to the position of the asparagine residue in the
HxB2 reference sequence.
doi:10.1371/journal.pcbi.0030011.t002
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Evolution of the HIV-1 Glycan Shieldthat these PNGSs are involved in any interactions. However,
three out of the four PNGS at which highly divergent
evolution occurred (N136, N234, and N362) have been
implicated by our study in interactions with other PNGSs.
Hence, the complexity of the adaptive response of the glycan
shield can be predicted by the interactions that we have
identiﬁed between PNGSs.
Moreover, we have found evidence of a novel association
between the distance separating PNGSs and the type of
interaction between them, which represents an additional
layer of constraints on the glycan shield. Negative, or
‘‘mutually exclusive,’’ interactions tended to occur between
PNGSs that occupied similar locations on the glycoprotein.
This tendency for overlapping or adjacent PNGS to be
mutually exclusive may have been caused by either steric
hinderance or functional redundancy. Because of the large
molecular weight of N-linked glycans, steric hindrance could
conceivably prevent glycans attached to overlapping PNGSs
from occupying the same space [2]. However, it is possible for
overlapping PNGSs offset by one residue to become simulta-
neously glycosylated [35]. Functional redundancy, on the
other hand, implies that having additional glycans at a given
location on the envelope glycoprotein would fail to provide
any further protection from neutralization while accruing a
debilitating cost to the normal functioning of the glycopro-
tein [36]. Either mechanism would enforce a maximum limit
on the number of PNGSs in the sequence, which could be
maximized by evenly distributing PNGSs across the protein
surface or functional space.
Positive interactions, on the other hand, tended to occur
exclusively between PNGSs that were separated by greater
distances. The observed relationship between spatial distance
and the interaction value (e) suggested a minimum distance
threshold of 20 A ˚ , separating glycans for them to become
nonredundant, i.e., to achieve complete coverage of the
antigenic surface of gp120 (Figure 1). For comparison, high
mannose and complex carbohydrates were estimated to
extend from the glycoprotein surface to a distance of
approximately 30–40 A ˚ and to have a maximum diameter
of about 15–40 A ˚ [37]. Evidence of positive interactions
between distant PNGS implies that the glycan shield is a
biological gestalt, unable to function until it achieves
complete coverage of HIV-1 envelope glycoproteins.
These spatial constraints predicted by our study comple-
ments a similar constraint that was previously put forth on
the basis of experimental results from Ohgimoto et al. [17], in
which the infectivity of a strain of SIV was sensitive to the
cumulative depletion of N-linked glycans speciﬁcally when
they were removed from a similar location on the gp120
glycoprotein. In other words, this experiment revealed a
selective advantage for maintaining a minimum local density
of glycans. Here we ﬁnd evidence of similar constraints
preventing the local density of glycans from exceeding a
maximum threshold, and maintaining a minimum overall
density of glycans on the HIV-1 envelope glycoproteins.
V3 Loop Glycan Interactions
The third variable loop (V3) is an immunologically and
functionally important region of the HIV-1 gp120 amino acid
sequence (reviewed in [38]). There are several conserved
PNGSs located within or adjacent to V3 (N289, N295, N301,
N332, and N339), which may function primarily to mask the
large number of neutralizing antibody epitopes deﬁned in
this region. Additionally, the PNGSs N295 and N332
contribute to the formation of a glycan-dependent epitope
that is recognized by the human monoclonal neutralizing
antibody 2G12 [14]. In light of these factors, we are
particularly interested in describing interactions involving
PNGSs that are associated with V3. For instance, our
disequon analysis revealed a strong negative interaction
between the PNGSs N295 and N337, where the latter replaces
N339 in a small number (n ¼ 21) of sequences belonging
mostly to subtypes B and C. In the presence of N337, the
PNGS at N295 was intact in only two sequences, suggesting
that N337 may provide an infrequently used alternative that
can provide similar protection for epitopes on V3, by shifting
the N-linked glycan from N339 closer to the space normally
occupied by N295. A second alternative for N295 may also be
provided by the PNGS N442, which is also located near the
base of V3 in the folded gp120 glycoprotein (Figure 3).
V4 Loop Glycan Interactions
An intriguing result from our phylogenetic and Bayesian
network analyses on the distribution of PNGS in HIV-1 env
sequences was the strong evidence of interactions involving
PNGSs that were located in the V4 loop of gp120 (N406,
N411, N413). Previous empirical studies have noted that the
modiﬁcation of PNGSs in V4 was prominent during
adaptation of HIV-1 and SIV to a novel host [11,34,39] and
that the addition or removal of PNGSs in V4 affected
neutralization sensitivity in a context-dependent fashion,
involving interactions with PNGSs located elsewhere in gp120
[11]. The V4 loop is an accessible and ﬂexible region in the
gp120 structure [33]. Glycans in V4 are apparently nones-
sential for CD4 binding, and the V4 region has not been
associated with any other known biological function of gp120
Figure 3. Interacting PNGS Mapped to Structural Model of gp120
Arcs from the consensus network are mapped to asparagine residues in
the structure of a folded CD4-bound gp120 protein. The host cell-
binding face of gp120 is oriented towards the top of the figure, and
variable loops (of which many residues are truncated) are highlighted in
pink. Arcs are colored red to indicate mutual exclusion, and blue
indicates co-occurrence of the PNGSs. The asparagine residues of
mutually exclusive PNGSs N295/N442 and N362/N465 are located within
;12 A ˚ of one another. In contrast, co-occurent PNGSs are separated by
much greater intramolecular distances.
doi:10.1371/journal.pcbi.0030011.g003
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Evolution of the HIV-1 Glycan Shield[40]. Therefore, the V4 region may exist solely to facilitate
viral escape as a component of the evolving glycan shield [41].
Using a disequon model, we found signiﬁcant interactions
between N411 and eight other PNGSs in the HIV-1 envelope
glycoproteins, of which six were located outside of V4 (Table
1). Six of these eight interactions were positive, suggesting that
N411 might represent a central component in a high-density
conﬁguration of the glycan shield. Indeed, sequences in which
a PNGS was present at N411 contained a signiﬁcantly greater
number of PNGSs in the rest of the sequence (generalized
linear model, Wald test: v1
2¼8.44, p , 0.004). Curiously, one
of these positive interactions implicated a PNGS (N824)
located on the cytoplasmic tail of the transmembrane
envelope glycoprotein gp41. This evidence of a functional
interaction between PNGSs situated on the gp120 V4 loop
extruding outward and the inner face of gp41 suggests that the
glycosylation state can be transmitted between these non-
covalently associated glycoproteins of the HIV-1 envelope,
perhaps by inducing a cascade of conformational change,
which has been postulated for amino acid substitutions and
deletions within gp41 in previous studies [42,43].
Implications for Vaccine Development
The N-linked glycosylation of the HIV-1 envelope glyco-
proteins is one of the most important protective mechanisms
to overcome in order to develop an effective neutralizing
antibody-inducing vaccine. Because several N-linked glyco-
sylation sites are relatively constant across HIV-1 subtypes,
there is a great deal of interest in developing a carbohydrate-
based antigen designed to elicit a humoral immune response
to HIV-1. However, even the N-linked glycan-dependent
epitope of the archetypal neutralizing antibody 2G12 is prone
to evolve to alternate glycans, as revealed in this study by the
negative interactions involving N295 or N332. It is imper-
ative, therefore, to identify vulnerabilities in the form of
functional constraints that limit the evolution of N-linked
glycosylation sites in HIV-1 gp120. Ultimately, the character-
ization of constraints in the glycan shield could enable us to
drive an evolving population of HIV-1 into a corner.
Although our phylogenetic and graphical models make
very different assumptions about the evolution of PNGSs, we
ﬁnd that these complementary approaches consistently
identiﬁed a set of interactions among N-linked glycosylation
sites in HIV-1 envelope glycoprotein sequences. Further-
more, the results from both methods support the hypothesis
that PNGSs that are located closer together in the glyco-
protein tend to be mutually exclusive, and that positive
interactions tend to occur between PNGSs that are more
remote. Not only is this pattern intuitively appealing, but it
may also represent a new and all-inclusive constraint on the
evolution of PNGSs in the HIV-1 envelope sequence.
Speciﬁcally, the tendency for negative interactions to occur
primarily between spatially localized PNGSs implies that
many N-linked glycans of divergent HIV-1 envelope glyco-
proteins are constrained to appear in very similar locations.
Furthermore, any analysis on the frequencies of individual
PNGSs in an alignment—especially those relating such
quantities to a viral phenotype such as neutralization
sensitivity—should count overlapping motifs as being effec-
tively the same PNGS, because these pairs tend to manifest
strong negative interactions that imply structural or func-
tional redundancy.
Materials and Methods
Phylogeny reconstruction. We obtained an alignment of published
full-length HIV-1 envelope sequences from the Los Alamos National
Laboratory HIV database (http://hiv-web.lanl.gov/content/hiv-db/
ALIGN_04/ALIGN-INDEX.html). This alignment comprised 711
sequences, including 660 sequences representing all HIV-1 main
(M) group subtypes, 44 sequences from group O, two sequences from
group N, and four sequences from chimpanzee isolates of SIV.
Conditional on the availability of patient or isolate annotation, this
alignment had been prescreened for redundant sequences so that
nearly every sequence represented a unique individual [44].
PNGSs were identiﬁed in the amino acid sequences by the
occurrence of a sequence motif (i.e., sequon) NX1(S/T)X2, where X
corresponds to any amino acid other than proline [2]. The position-
speciﬁc frequencies of PNGSs in the alignment are reported in Figure
S1. Any number of gaps in an aligned sequence was permitted to
occur between residues within this motif. Amino acid sequence
motifs deﬁning overlapping PNGSs (e.g., NNSS) were counted as two
distinct occurrences. Codon positions that deﬁned a PNGS in at least
one sequence were removed from the nucleotide alignment, which
was subsequently used to reconstruct the phylogeny by neighbor-
joining [45] using the Tamura-Nei [46] distance measure. Non-
parametric bootstrap support values for the branches of this tree are
reported in Figure S2.
Phylogenetic analyses. The HIV-1 envelope amino acid alignment
was converted into binary sequences indicating the presence (1) or
absence (0) of an asparagine (N) residue that initiated a PNGS at that
position. We ﬁltered all columns from the binary alignment in which
no 1 entries occurred, and applied the remaining columns to the
covarion and disequon model analyses that were implemented using
the HyPhy batch language (available from http://www.hyphy.org/pubs/
PNGS) [47].
The covarion model evaluated variation over time in the site-
speciﬁc rates that PNGSs were gained or lost, i.e., r1!0 and r0!1,
respectively. Each position in the binary alignment was permitted to
switch between two hidden states, such that one state was on (r0!1,
r1!0 . 0) and the second was off (r0!1, r1!0 . 0). Switches between
these hidden states occurred at instantaneous rates son and soff. Both
sets of rates were allowed to vary among positions according to
factors drawn from discretized one-parameter gamma distributions.
Further details on the covarion model and the constrained
alternative models are provided in Protocol S1.
For the disequon model analysis, we generated all pairwise
combinations of columns, resulting in four possible binary paired-
character states: f00, 01, 10, 11g. Simultaneous substitutions at both
sites were assumed to occur at a negligibly low rate, leaving eight
possible substitution rates to parameterize. The full disequon model
depended on four parameters (Figure 4): b1 and b2, which quantiﬁed
the asymmetry in the rate of loss over gain at the respective sites (e.g.,
b1 ¼ r1 !0 /r0 !1 ); the difference (d) in the overall evolutionary rate
between the ﬁrst and second sites; and an interaction parameter (e).
When e . 1, the gain of a PNGS at one site elevated the rate of gain at
the other site, and the loss of a PNGS elevated the rate of loss at the
other site. Conversely, when e , 1, the gain of a PNGS at one site
elevated the rate of loss at the other site, and vice versa. We also
evaluated a version of this model with an additional interaction
parameter acting speciﬁcally on the rates r01!11 and r10!11,
decoupling effects of interactions on the coupled gain and loss of
PNGSs. However, the additional parameter produced no signiﬁcant
improvement of likelihood and we proceeded with the simpler model.
The disequon model was hence represented by the following time-
reversible rate matrix:
00 01 10 11
Qd ¼
  d 10
edb2   0 e
eb1 0   ed
0 b1 db2  
0
B B @
1
C C A
00
01
10
11
ð1Þ
in which the rows list substitution rates from their respective states to
the state indicated above each column, and the diagonal elements (*)
assumed values such that each row summed to 0. Note that estimation
of the rate r00!10 is confounded by branch length estimates; hence, it
was ﬁxed at 1. The stationary distribution for this model is given by pd
} fb1b2e, b1, b2, eg, normalized to sum to 1. We ﬁtted the disequon
model to each pairwise combination of PNGSs from the alignment,
using branch lengths that were constrained to be proportional to the
lengths from the non-PNGS tree, given a global scaling factor.
Pairwise combinations in which at least one of the four states was
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Evolution of the HIV-1 Glycan Shieldabsent were excluded from the analysis, reducing the total number of
comparisons from 49,952 to 6,455 pairs and improving the stability of
model inference. A pair had a signiﬁcant interaction component (e 6¼
1) if the likelihood of the full model was signiﬁcantly greater than that
of the nested model in which e was constrained to 1, i.e., by evaluating
the LRT against the asymptotic null v
2 distribution with 1 degree of
freedom. We applied a Bonferroni correction to account for multiple
comparisons. This procedure is far more conservative than alter-
native procedures such as the false discovery rate [48]. Using the false
discovery rate would have also required accurate estimation of the
distribution of p-values under the null hypothesis, which was limited
by the complexity of the likelihood surface for this model.
Bayesian network analysis. We chose a subset of PNGS that were
present in at least 20% but fewer than 80% of the sequences in the
alignment. This requirement for intermediate frequencies greatly
reduced the number of PNGSs, and hence the total number of
possible networks, while retaining statistical power for detecting
intersite dependencies. Each PNGS was represented as a discrete
(binary state) variable indicating the presence or absence of the N-
linked glycosylation sequence motif at a given position in an amino
acid sequence. Context-dependence between PNGSs were repre-
sented by directed arcs in a Bayesian network, so that an arc
originating from A and terminating at B indicated that the probability
of ﬁnding a PNGS at position B was conditionally dependent on
whether or not a PNGS occurred at position A. Likewise, the absence
of a directed arc indicated conditional independence between
PNGSs. Our objective was therefore to estimate the joint probability
distribution (encoded by the structure of directed arcs in the Bayesian
network) that provided the best explanation for the distribution of
PNGSs in the alignment of HIV-1 envelope sequences.
To infer, or ‘‘learn,’’ the structure of the network from the data, we
used a parallel implementation of a greedy heuristic search algorithm
with random restarts in Java [49]. We used a heuristic search
algorithm because it was computationally infeasible to iterate over
all possible networks (’6.3 3 10
52 possible networks for 17 PNGSs).
Our greedy heuristic search algorithm was based on the K2 algorithm,
which assumed that the dataset contained no missing values and that
the prior probability distributions were uniform (i.e., such that the
conditional probability P(A ¼ 1 j B ¼ 1) was equally likely to assume
any real value within the interval [0,1]) [50]. Each search was
initialized with a randomized network assembled by applying 100
modiﬁcations (i.e., addition, removal, or reversal of a directed arc) to
an unconnected set of nodes, provided that the graph remained
acyclic. Subsequently, the search algorithm iteratively evaluated the
relative improvement in the posterior probability of the network
from the addition, removal, or reversal of a directed arc to the
current network structure, and the best modiﬁcation was incorpo-
rated into the network. This iterative process continued until no
further improvement in posterior probability was possible.
We applied this search algorithm to 100 random samples of 200
sequences from the alignment to evaluate the variation in the optimal
network structure among sequences. The greedy search algorithm was
applied to each sample with 250 random restarts to explore multiple
local maxima in the scoring metric (i.e., posterior probability).
Networks evaluated by the search algorithm were restricted to the
subset of all possible networks in which each node had a maximum
number of ﬁve parents. The restriction of the number of parent
nodes to ﬁve or fewer per node was necessary to reduce the size of the
search space. However, none of the locally optimal models found by
our search algorithm included nodes with ﬁve parents, suggesting
that the data favored simpler models. The number of occurrences of
each arc, irrespective of its direction, was tabulated across all
networks obtained by the search algorithm for every sample. From
this table, we generated a majority-rule consensus network into which
an undirected arc between the nodes A and B was incorporated if the
sum of tabulated frequencies of the directed arcs A ! B and B ! A
exceeded a threshold value of 50%. Posterior odds-ratios for each arc
in the consensus network were calculated from 2 3 2 contingency
tables of posterior parameters. For this calculation, undirected arcs
in the consensus network were assigned directionality according to
which directed arc had been sampled at a greater frequency.
Undirected arcs in the consensus network were classiﬁed as
representing either positive (inclusive) or negative (exclusive)
associations between PNGS, as determined by calculating the
posterior odds-ratios from the corresponding 2 3 2 contingency
tables of posterior parameters. For example, the contingency table
for the PNGSs N411 and N413 contained the following:
N411
N413
01
0 6056 9517
1 594 3837
from which the posterior-odds ratio was calculated as:
PðN411 ¼ 1jN413 ¼ 1Þ
PðN411 ¼ 1jN413 ¼ 0Þ
¼
594=ð594 þ 3837Þ
6056=ð6056 þ 9517Þ
’0:34
indicating that N411 was only one-third as likely to occur in a
sequence that also contained a PNGS at position N413. Hence, an
odds-ratio greater than 1 implied that the PNGSs were inclusive,
whereas an odds-ratio less than 1 implied that they were mutually
exclusive.
Because of the limited number of sequences within the HIV-1
subtypes, our analysis of subtype-speciﬁc networks was carried out
using an MCMC-based procedure that is designed for inferring
networks from relatively small datasets [51]. When the amount of data
is small relative to the number of network variables, an exceedingly
large number of networks may explain the data equally well. Rather
than attempting to ﬁnd an optimal network, this procedure estimates
the overall posterior probability for the presence of each arc given
the data. To traverse the enormous network search space more
efﬁciently, a hierarchical order of network variables is proposed at
each step, corresponding to a subset of networks in which every node
is preceded by its parent in the ordered list [51]. We applied this
procedure with a coupled Metropolis-Hasting sampling algorithm
with at least four chains [52] to analyze subtype data.
Visualization of protein structure. We obtained structural coor-
dinates for the HIV-1 glycoprotein gp120 in complex with a CD4
receptor from the Research Collaboratory for Structural Bioinfor-
matics[33].ThelocationofPNGSsinthegp120structurewasvisualized
usingthesoftwarepackageUCSFChimera[53].Notethatseveralofthe
gp120 variable loops are absent from this structural prediction.
Supporting Information
Figure S1. Frequency of PNGSs per Codon Position in HIV-1
Envelope Sequences
Codon positions are numbered according to the alignment of HIV-1
envelope sequences. The approximate locations of variable loop
regions and the transition between the gp120 and gp41 glycoprotein-
coding domains are marked for reference. The frequency of PNGSs is
Figure 4. Disequon Model Parameters
This diagram illustrates the eight rates that are parameterized by the
disequon(paired-character) model.Each box corresponds to a state in the
disequon model, in which the first digit represents the presence or
absenceofaPNGSatthefirstsite,andtheseconddigitforthesecondsite.
The interaction parameter (e) between paired sites is highlighted in red.
doi:10.1371/journal.pcbi.0030011.g004
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Evolution of the HIV-1 Glycan Shieldnormalized by the total number of sequences in the alignment
(PNGSs fraction).
Found at: doi:10.1371/journal.pcbi.0030011.sg001 (35 KB PDF).
Figure S2. Bootstrap Tree of HIV-1 Envelope Sequences
Internal branches are colored red to indicate .70% bootstrap
support, green to indicate 50%–70% bootstrap support, and black
otherwise. Bootstrap support values were estimated from 100
replicate samples. Branch lengths are derived from the neighbor-
joining tree [45] based on the Tamura-Nei [46] distance measure,
applied to the nucleotide alignment excluding positions at which
PNGSs are deﬁned.
Found at doi:10.1371/journal.pcbi.0030011.sg002 (43 KB PDF).
Protocol S1. Formulation of Covarion Model of PNGSs Evolution
Found at doi:10.1371/journal.pcbi.0030011.sd001 (58 KB DOC).
Table S1. Goodness-of-Fit and Parameter Estimates for Covarion and
Nested Models
Found at doi:10.1371/journal.pcbi.0030011.st001 (81 KB PDF).
Table S2. Position and Frequency of Polymorphic PNGSs Applied to
Bayesian Networks
Found at doi:10.1371/journal.pcbi.0030011.st002 (37 KB DOC).
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